Skip to content
  • CME
  • NASH & Diabetes
    • Register For a Tailored Experience
    • S1-E3 – Diabetes Drug Choices With Benefits For NAFLD
    • S1-E2 — What’s Behind The New AACE Fatty Liver Guidelines?
    • S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  • NASH Tsunami
    • Season 4 (2023)
    • Season 3 (2022)
      • Year In Review 2022
    • Season 2 (2021)
      • Year In Review 2021
    • Season 1 (2020)
      • Year In Review 2020
    • Most Popular Episodes
  • Events
    • 2021 Events
      • AASLD TLMdX 2021
      • EASl ILC 2021
      • NASH-TAG 2021
  • Sponsorships
    • Our Sponsors & Affiliates
    • Sponsorship Programs
  • Surfers
  • Contact
Menu
  • CME
  • NASH & Diabetes
    • Register For a Tailored Experience
    • S1-E3 – Diabetes Drug Choices With Benefits For NAFLD
    • S1-E2 — What’s Behind The New AACE Fatty Liver Guidelines?
    • S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  • NASH Tsunami
    • Season 4 (2023)
    • Season 3 (2022)
      • Year In Review 2022
    • Season 2 (2021)
      • Year In Review 2021
    • Season 1 (2020)
      • Year In Review 2020
    • Most Popular Episodes
  • Events
    • 2021 Events
      • AASLD TLMdX 2021
      • EASl ILC 2021
      • NASH-TAG 2021
  • Sponsorships
    • Our Sponsors & Affiliates
    • Sponsorship Programs
  • Surfers
  • Contact
Log In
Bars
Test The PopUp

Listen Now

Apple Spotify Youtube
Copyright © SurfingNASH.Com 2023
Linkedin Facebook Twitter Instagram
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT

Does It Close?

Log In
  • CME
  • NASH & Diabetes
    • Register For a Tailored Experience
    • S1-E3 – Diabetes Drug Choices With Benefits For NAFLD
    • S1-E2 — What’s Behind The New AACE Fatty Liver Guidelines?
    • S1-E1 – Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
  • NASH Tsunami
    • Season 4 (2023)
    • Season 3 (2022)
      • Year In Review 2022
    • Season 2 (2021)
      • Year In Review 2021
    • Season 1 (2020)
      • Year In Review 2020
    • Most Popular Episodes
  • Events
    • 2021 Events
      • AASLD TLMdX 2021
      • EASl ILC 2021
      • NASH-TAG 2021
  • Sponsorships
    • Our Sponsors & Affiliates
    • Sponsorship Programs
  • Surfers
  • Contact
Stay In Touch
Apple Spotify Youtube
Apple Spotify Youtube Soundcloud

NASH & Diabetes Podcast and NASH Tsunami Podcast

S1-E3 - Diabetes Drug Choices With Benefits For NAFLD

S1-E3 – Diabetes Drug Choices With Benefits For NAFLD

Hepatologist Naim Alkhouri and Endocrinologist Scott Isaacs join Ken Cusi and Roger Green to discuss drug choices prescribers can make

Learn More »
  • January 25, 2023

S4-5 – Predictive Health Intelligence: Using Historic Blood Test Results to Identify Risk of Fatty Liver

  • January 22, 2023

S4-4.6 – Donna Cryer on Aligning Regulatory Science and Expanding Avenues for Advocacy

  • January 22, 2023

S4-4.5 – Patient Advocates on “Getting the Message Out” as Approval of Drugs Approaches

  • January 22, 2023

S4-4.4 – NASH-TAG 2023: Emerging Optimism from a Watershed Moment

  • January 21, 2023

S4-4.3 – Surfing NASH Community Interview with Caitlin Schneider of Sonic Incytes

  • January 21, 2023

S4-4.2 – Surfing NASH Community Interview with Jerry Mabary of Chronwell

  • January 21, 2023

S4-4.1 – Surfing NASH Community Interview with Pamela Danagher of Terns Pharmaceuticals

  • January 18, 2023

S4-4 – Surfing NASH Audience Reacts to NASH-TAG and the Future of Fatty Liver

  • January 16, 2023

S4-3.6 – Interview with Co-founder & CSO of HistoIndex, Dean Tai, on AI-Assisted Histology

  • January 16, 2023

S4-3.5 – NASH-TAG Review: Donna Cryer on “Good Regulatory Science”

More Episodes

Experience Nudge Learning! Interested in a new way of learning?

Learn More About CME